Literature DB >> 10882608

Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans.

T S Harrison1, G E Griffin, S M Levitz.   

Abstract

Chloroquine at 10 microM enhances the activity of macrophages against Cryptococcus neoformans but does not directly inhibit cryptococcal growth. The antifungal activity of higher chloroquine concentrations likely to be found within the acidic cryptococcal phagosome was tested. Concentrations of >/=30 microM inhibited cryptococcal growth, and there was fungal killing at concentrations of >/=100 microM. Activity was dependent on physiologic temperature and pH. Quinacrine was 50-fold more active than chloroquine, and concentrations as low as 100 nM enhanced macrophage anticryptococcal activity. Quinacrine was concentrated within a vacuolar system within the fungal cell and highly concentrated within intracellular C. neoformans. Ammonium chloride and bafilomycin A both inhibited cryptococcal growth, suggesting that the activity of chloroquine and quinacrine may in part be due to disruption of pH-dependent processes. These findings add to the known spectrum of activity of chloroquine and quinacrine. These, and related compounds, may have utility for the treatment of cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882608     DOI: 10.1086/315649

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  Activity of picolinic acid in combination with the antiprotozoal drug quinacrine against Mycobacterium avium complex.

Authors:  Toshiaki Shimizu; Haruaki Tomioka
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines.

Authors:  D Taramelli; C Tognazioli; F Ravagnani; O Leopardi; G Giannulis; J R Boelaert
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.

Authors:  Hiram Villanueva-Lozano; Rogelio de J Treviño-Rangel; Gloria M González; Pedro A Hernández-Rodríguez; Adrián Camacho-Ortiz; Luis Castillo-Reyna; Sandra G Galindo-Alvarado; Michel F Martínez-Reséndez
Journal:  Infection       Date:  2017-08-16       Impact factor: 3.553

Review 5.  Intracellular pathogenic bacteria and fungi--a case of convergent evolution?

Authors:  James B Bliska; Arturo Casadevall
Journal:  Nat Rev Microbiol       Date:  2008-12-22       Impact factor: 60.633

6.  An unusual organelle in Cryptococcus neoformans links luminal pH and capsule biosynthesis.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Fungal Genet Biol       Date:  2009-05-18       Impact factor: 3.495

Review 7.  Cryptococcal therapies and drug targets: the old, the new and the promising.

Authors:  Carolina Coelho; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2016-04-08       Impact factor: 3.715

8.  Role of urease in megasome formation and Helicobacter pylori survival in macrophages.

Authors:  Justin T Schwartz; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2006-03-16       Impact factor: 4.962

9.  Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.

Authors:  Gary M Cox; Thomas S Harrison; Henry C McDade; Carlos P Taborda; Garrett Heinrich; Arturo Casadevall; John R Perfect
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 10.  An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans.

Authors:  James W Kronstad; Guanggan Hu; Won Hee Jung
Journal:  Trends Microbiol       Date:  2013-06-25       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.